Message from the Director
The Center for Drug Design combines the best of academic tradition along with an expectation of innovation and independence, and provides significant value for our academic and research community.
Research on Alzheimer's Disease by Prof Vince and Prof More Featured on C&EN News
Eye Test Might One Day Diagnose Alzheimer’s Before Symptoms Appear
Prof Chen's Research on Parkinson’s Disease featured by the University
Drug Design for Parkinson’s Disease Starts Here
Prof. Salomon's Research Highlighted in MNDaily
Christine Salomon: Underground Research Drives Drug Research
Adegboyega K. Oyelere, PhD
School of Chemistry & Biochemistry
Georgia Institute of Technology
Date: January 21, 2015
Time: 10:30 AM
Venue: 2-650 Moos Towers
The overarching research objective of Prof Oyelere's laboratory is to delineate the chemical basis of the molecular recognition events employed by biomolecules to drive important biological processes. They are interested in how perturbation of molecular recognition, by natural and synthetic ligands, can be used to understand the molecular basis of biological processes.
New Course Offering
HIV Drug Discovery (AHS 5100)
This course has been designed to cultivate an understanding of virology, medicinal chemistry, pharmacology, and regulatory aspects related to HIV drug discovery. It will be most beneficial to students with a strong background in science, and an interest in a career in various aspects of drug discovery.
Prerequisites: One year of organic chemistry (CHEM 2301 and 2302) or equivalent AND One semester of biochemistry (BIOC 3021) or equivalent, are required.
Schedule: 01/20/2015 - 05/08/2015 (T, Th); 08:15 AM - 09:30 AM
Venue: PWB 6-210
Credits awarded: 3